Is Bristol-Myers Squibb (BMY) halal?
No — BMY fails the AAOIFI Sharia screen on at least one of business activity, debt, or interest income.
Fails one or more AAOIFI screens — see details below. Not investment advice.
Recent insider buys (SEC Form 4)
No disclosed Form 4 insider purchases recorded for BMY recently.
Congressional trades (STOCK Act)
| Filed | Member | Chamber | Buy band | Δ1d | Δ7d |
|---|---|---|---|---|---|
| Jul 21, 2026 | Alan Armstrong | Senate | $1K–$15K | +1.00% | +5.72% |
Federal contracts
Largest awards active in the covered window. A contract's start date can predate the window.
| Start | Agency | What for | Obligated | Source |
|---|---|---|---|---|
| Sep 30, 2026 | Department of Veterans Affairs | CAMZYOS AND POMALYST | $1.0M | award |
| Dec 30, 2025 | Department of Veterans Affairs | REVLIMID, POMALYST, CAMZYOS SPECIALTY PHARMACEUTICALS | $848K | award |
| May 14, 2025 | Department of Veterans Affairs | EMERGENCY BREYANZI INFUSION | $670K | award |
| Mar 12, 2026 | Department of Veterans Affairs | ABECMA FOR CAR-T | $379K | award |
| Aug 9, 2026 | Department of Veterans Affairs | ABECMA INJECTION | $379K | award |
Coverage from 2024-01 · updated 2026-10-11 · source USAspending.gov
Lobbying disclosures
| Quarter | Reported | What this figure is | Filings |
|---|---|---|---|
| 2026 Q2 | $3.2M | The company’s own filing, including what it paid outside firms | 8 |
| 2026 Q1 | $1.3M | The company’s own filing, including what it paid outside firms | 8 |
| 2025 Q4 | $1.3M | The company’s own filing, including what it paid outside firms | 5 |
| 2025 Q3 | $3.2M | The company’s own filing, including what it paid outside firms | 5 |
| 2025 Q2 | $4.8M | The company’s own filing, including what it paid outside firms | 3 |
| 2025 Q1 | $870K | The company’s own filing, including what it paid outside firms | 3 |
| 2024 Q4 | $790K | The company’s own filing, including what it paid outside firms | 3 |
| 2024 Q3 | $3.3M | The company’s own filing, including what it paid outside firms | 5 |
Recent filings:2026 FEDERAL STREET STRATEGIES, LLC2026 TODD STRATEGY GROUP2026 BRISTOL-MYERS SQUIBB COMPANY2026 MILLER STRATEGIES, LLC2026 WILLIAMS AND JENSEN, PLLC
Coverage from 2024-01 · updated 2026-10-11 · source lda.gov
Cross-source consensus events
| Fired | Kind | Sources | Score |
|---|---|---|---|
| Oct 1, 2026 | cross-source | news, executive | 3.44 |
| Sep 24, 2026 | cross-source | news, executive | 2.14 |
| Jul 21, 2026 | cross-source | news, congress | 2.92 |
See every insider, Congress & 13F move — with a halal check on BMY. Free to start.
Start freeGet the biggest insider & Congress buys every Sunday — free.
FAQ
Is Bristol-Myers Squibb (BMY) halal?
No — BMY fails the AAOIFI Sharia screen on at least one of business activity, debt, or interest income.
Have insiders been buying BMY?
No disclosed SEC Form 4 insider purchases for BMY in the last 90 days.
Which members of Congress traded BMY?
Recent disclosed BMY trades came from: Alan Armstrong.
Does BMY have federal government contracts?
$9.8M in federal contract obligations over the last 12 months, per USAspending.gov data covering 2024-01 onward.
How much does BMY spend on lobbying?
$3.2M in 2026 Q2, per Lobbying Disclosure Act filings.